home / stock / itci / itci news


ITCI News and Press, Intra-Cellular Therapies Inc. From 04/18/24

Stock Information

Company Name: Intra-Cellular Therapies Inc.
Stock Symbol: ITCI
Market: NASDAQ
Website: intracellulartherapies.com

Menu

ITCI ITCI Quote ITCI Short ITCI News ITCI Articles ITCI Message Board
Get ITCI Alerts

News, Short Squeeze, Breakout and More Instantly...

ITCI - Intra-Cellular Therapies drops 2%, prices $500M equity financing

2024-04-18 02:47:32 ET More on Intra-Cellular Therapies Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data Intra-Cellular Therapies Is On Fire Intra-Cellular Therapies gains on meeting main goal in trial for its depression treatment I...

ITCI - ENPH, OCUL and ITCI are among after hour movers

2024-04-16 17:02:18 ET Gainers: United Airlines Holdings ( UAL ) +6% . American Airlines Group ( AAL ) +2% . Enphase Energy ( ENPH ) +2% . Absci Corporation ( ABSI ) +1% . Ocular Therapeutix ( OCUL ) +1% . Losers: J.B. Hu...

ITCI - US Companies Moving the Markets, Evening edition
Tue, Apr 16, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 50.1% to $0.1783 on volume of 599,794,977 shares WiSA Technologies Inc. (WISA) rose 248.6% to $6.1 on volume of 197,912,579 shares PROSHARES TRUST (SQQQ) rose 0.0% to $11.44 on volume of 182,001,060 shar...

ITCI - Intra-Cellular Therapies announces proposed public offering of common stock

2024-04-16 16:10:43 ET More on Intra-Cellular Therapies Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data Intra-Cellular Therapies Is On Fire Intra-Cellular files lawsuits challenging Caplyta generics Read the full article on Seeki...

ITCI - Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data

2024-04-16 13:17:12 ET Summary Intra-Cellular Therapies, Inc. achieved positive results from Study 501, using lumateperone as an adjunctive therapy for the treatment of patients with MDD; Both primary and secondary endpoints achieved with statistical significance. The Major Depres...

ITCI - JAGX, BSGM and SXTC among mid-day movers

2024-04-16 12:40:38 ET More on Mid-day movers & stocks. Jaguar Health, Inc. (JAGX) Q4 2023 Earnings Call Transcript Jaguar Health shareholders approve reverse stock split BioSig Technologies to reduce its internal workforce to cut down costs Seeking Alpha...

ITCI - Intra-Cellular Therapies Inc. (NASDAQ: ITCI) Climbs to New 52-Week High

Shares of Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) traded at a new 52-week high today and are currently trading at $80.66. So far today, approximately 2.54M shares have been exchanged, as compared to an average 30-day volume of 533.56k shares. Intra-Cellular Therapies, Inc., a biopharmac...

ITCI - US Companies Moving the Markets, Morning edition
Tue, Apr 16, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 37.1% to $0.1629 on volume of 102,747,129 shares WiSA Technologies Inc. (WISA) rose 69.1% to $2.96 on volume of 24,734,833 shares Peraso Inc. (PRSO) rose 37.0% to $1.7393 on volume of 23,546,162 shares ...

ITCI - Notable Newsmakers

2024-04-16 09:29:31 ET DENVER, Colo., Apr 16, 2024 ( 247marketnews.com )- Palisade Bio, Inc. (Nasdaq: PALI ), Brera Holding (NASDAQ: BREA ), Peraso Inc. (NASDAQ: PRSO ), BioRestorative Therapies, Inc. (NASDAQ: BRTX ), and Intra-Cellular Ther...

ITCI - Intra-Cellular Therapies gains on meeting main goal in trial for its depression treatment

2024-04-16 09:01:36 ET More on Intra-Cellular Therapies Intra-Cellular Therapies Is On Fire Intra-Cellular Therapies, Inc. (ITCI) Q4 2023 Earnings Call Transcript Intra-Cellular Therapies: Buoyant Caplyta Sales And Upcoming MDD Data Support Short-Term 'Buy' I...

Previous 10 Next 10